Diclazuril-d4

Diclazuril-d4 is deuterium labeled Diclazuril. Diclazuril (R-64433), a benzeneacetonitrile derivative, is a potent and orally active anticoccidial agent. Diclazuril can be used for the research of certain infectious and parasitic diseases, including coccidiosis, acute toxoplasmosis, equine protozoal pyoencephalitis (EPM) et.al[1][2].

Product Specifications

CAS Number

[1632495-80-7]

Product Name Alternative

R-64433-d4

UNSPSC

12352005

Target

Antibiotic; Isotope-Labeled Compounds; Parasite

Type

Isotope-Labeled Compounds

Related Pathways

Anti-infection; Others

Applications

COVID-19-immunoregulation

Field of Research

Infection

Purity

98.00

Solubility

10 mM in DMSO|DMSO : 25mg/mL (ultrasonic)

Smiles

O=C1N(N=CC(N1)=O)C2=CC(Cl)=C(C(Cl)=C2)C(C3=C([2H])C([2H])=C(C([2H])=C3[2H])Cl)C#N

Molecular Formula

C17H5D4Cl3N4O2

Molecular Weight

411.66

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Diaferia, M., et al., Efficacy of toltrazuril 5 % suspension (Baycox (R), Bayer) and diclazuril (Vecoxan (R), Janssen-Cilag) in the control of Eimeria spp. in lambs. Parasitol Res, 2013. 112 Suppl 1: p. 163-8.|[3]http://www.huvepharma.com/products/view/190